InterCure Ltd. (NASDAQ:INCR) Sees Large Decrease in Short Interest

InterCure Ltd. (NASDAQ:INCR) saw a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 13,900 shares, a decrease of 21.9% from the October 15th total of 17,800 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average daily volume of 28,600 shares, the days-to-cover ratio is currently 0.5 days.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of INCR. Jane Street Group LLC bought a new stake in InterCure during the 3rd quarter valued at $49,000. Renaissance Technologies LLC boosted its position in InterCure by 30.9% during the second quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after purchasing an additional 10,700 shares in the last quarter. AdvisorShares Investments LLC purchased a new position in InterCure in the second quarter valued at about $218,000. Finally, Tidal Investments LLC bought a new position in InterCure in the first quarter worth about $883,000. Institutional investors own 8.34% of the company’s stock.

InterCure Price Performance

InterCure stock traded down $0.07 during mid-day trading on Friday, hitting $1.17. The company’s stock had a trading volume of 142,958 shares, compared to its average volume of 37,305. InterCure has a one year low of $1.06 and a one year high of $3.72. The company has a 50 day moving average of $1.76 and a 200-day moving average of $2.21. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.15 and a current ratio of 1.78.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.